BTD
EW icon

BankPlus Trust Department’s Edwards Lifesciences EW Stock Holding History

BankPlus Trust Department’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
12,075
+200
+2% +$16.8K 0.26% 83
2026
Q1 		$951K Buy
11,875
+80
+0.7% +$6.6K 0.25% 87
2025
Q4 		$1.01M Buy
11,795
+71
+0.6% +$5.83K 0.26% 83
2025
Q3 		$912K Sell
11,724
-183
-2% -$14.3K 0.24% 83
2025
Q2 		$931K Buy
11,907
+391
+3% +$29.2K 0.28% 74
2025
Q1 		$835K Buy
11,516
+115
+1% +$8.23K 0.28% 75
2024
Q4 		$844K Buy
+11,401
New +$798K 0.28% 75

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

BankPlus Trust Department's EW Position: Q2 2026 in Review

BankPlus Trust Department increased its Edwards Lifesciences (EW) stake by 1.7% in Q2 2026, buying an estimated $16.8K and bringing the position to 12,075 shares worth $1.09M. The position accounts for 0.26% of the portfolio, ranked #83.

BankPlus Trust Department first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • BankPlus Trust Department held 12,075 shares of Edwards Lifesciences worth $1.09M as of Q2 2026.
  • BankPlus Trust Department bought 200 Edwards Lifesciences shares in Q2 2026, an estimated $16.8K.
  • Edwards Lifesciences made up 0.26% of BankPlus Trust Department's portfolio in Q2 2026, its #83 holding.
  • BankPlus Trust Department first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.